9.75

12.87% +1.05

Canopy Growth Corporation (CGC)

Overview News Price History Option Chain Why CGC Down? Discussions Forecast

Canopy Growth Corporation stock is currently priced at $9.75, with a 24-hour trading volume of 6.55M. It has seen a +12.87% increased in the last 24 hours and a +35.82% rose in the past month. The chart indicates a potential bullish trend, as the stock is above the $8.81 pivot point. If it approaches the $9.45 resistance level, significant changes may occur.

Previous Close:

$8.70

Open:

$8.8

24h Volume:

6.55M

Market Cap:

$792.70M

Revenue:

$292.26M

Net Income/Loss:

$-891.68M

P/E Ratio:

-5.5537

EPS:

-1.7556

Net Cash Flow:

$-310.42M

1W Performance:

+23.83%

1M Performance:

+35.82%

6M Performance:

+89.50%

1Y Performance:

-22.68%

1D Range:

$8.77

$10.24

52W Range:

$2.755

$19.20

Canopy Growth Corporation Stock (CGC) Company Profile

Name

Canopy Growth Corporation

Sector

Healthcare (1198)

Industry

Drug Manufacturers - Specialty & Generic (4)

Phone

855-558-9333

Address

1 Hershey Drive, Smiths Falls, ON

Employee

2,000

Twitter

@CanopyGrowth

Next Earnings Date

2024-02-09

Latest SEC Filings

CGC's Discussions on Twitter

Canopy Growth Corporation Stock (CGC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-04-23	Upgrade	Bernstein	Underperform → Mkt Perform
Nov-02-22	Initiated	Bernstein	Underperform
Oct-26-22	Upgrade	Canaccord Genuity	Sell → Hold
Jun-08-22	Downgrade	BMO Capital Markets	Market Perform → Underperform
Mar-22-22	Downgrade	Barclays	Equal Weight → Underweight
Dec-22-21	Downgrade	BofA Securities	Neutral → Underperform
Dec-20-21	Downgrade	Piper Sandler	Neutral → Underweight
Dec-07-21	Initiated	Wells Fargo	Underweight
Nov-18-21	Initiated	Barclays	Equal Weight
Nov-08-21	Downgrade	CIBC	Neutral → Sector Underperform
Nov-08-21	Downgrade	Canaccord Genuity	Hold → Sell
Nov-08-21	Downgrade	Cowen	Outperform → Market Perform
Oct-01-21	Downgrade	BofA Securities	Buy → Neutral
Aug-12-21	Upgrade	Jefferies	Underperform → Hold
Jun-02-21	Upgrade	Canaccord Genuity	Sell → Hold
May-25-21	Upgrade	MKM Partners	Neutral → Buy
Apr-28-21	Resumed	BofA Securities	Buy
Feb-24-21	Downgrade	Jefferies	Hold → Underperform
Feb-10-21	Downgrade	Canaccord Genuity	Hold → Sell
Feb-10-21	Downgrade	The Benchmark Company	Buy → Hold
Feb-05-21	Downgrade	Piper Sandler	Overweight → Neutral
Sep-04-20	Upgrade	CFRA	Buy → Strong Buy
Jun-01-20	Downgrade	BMO Capital Markets	Outperform → Market Perform
Jun-01-20	Downgrade	Bryan Garnier	Neutral → Sell
Jun-01-20	Downgrade	CIBC	Sector Outperform → Neutral
Jun-01-20	Downgrade	Ladenburg Thalmann	Buy → Neutral
Jun-01-20	Downgrade	Stifel	Buy → Sell
May-22-20	Resumed	BofA/Merrill	Buy
Apr-16-20	Upgrade	Jefferies	Underperform → Hold
Jan-28-20	Upgrade	BMO Capital Markets	Market Perform → Outperform
Dec-12-19	Reiterated	Cantor Fitzgerald	Neutral
Nov-20-19	Upgrade	BofA/Merrill	Neutral → Buy
Nov-15-19	Downgrade	Alliance Global Partners	Buy → Neutral
Nov-05-19	Initiated	Cantor Fitzgerald	Neutral
Oct-14-19	Downgrade	Seaport Global Securities	Buy → Neutral
Oct-11-19	Downgrade	Jefferies	Hold → Underperform
Sep-27-19	Downgrade	BofA/Merrill	Buy → Neutral
Sep-20-19	Initiated	MKM Partners	Neutral
Sep-18-19	Initiated	Oppenheimer	Perform
Aug-26-19	Upgrade	Seaport Global Securities	Neutral → Buy
Jul-17-19	Initiated	Ladenburg Thalmann	Buy

View All

Canopy Growth Corporation Stock (CGC) Latest News

Canopy Growth Corporation Stock (CGC) Financials Data

Canopy Growth Corporation (CGC) Revenue 2024

CGC reported a revenue (TTM) of $292.26 million for the quarter ending December 31, 2023, a -0.25% decline year-over-year.

Canopy Growth Corporation (CGC) Net Income 2024

CGC net income (TTM) was -$891.68 million for the quarter ending December 31, 2023, a +64.43% increase year-over-year.

Canopy Growth Corporation (CGC) Cash Flow 2024

CGC recorded a free cash flow (TTM) of -$310.42 million for the quarter ending December 31, 2023, a +26.37% increase year-over-year.

Canopy Growth Corporation (CGC) Earnings per Share 2024

CGC earnings per share (TTM) was -$15.11 for the quarter ending December 31, 2023, a +75.31% growth year-over-year.

Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, Bedrocan Canada, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.